AlphaYouEH
Insider selling
Elizabeth H.Z. Thompson sold $433K of Acadia Pharmaceuticals Inc (ACAD) stock
Elizabeth H.Z. Thompson, EVP, Head of Research & Dev of Acadia Pharmaceuticals Inc (ACAD), sold 16,558 shares of ACAD stock worth $433K, per an SEC Form 4 filed Jul 31, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 29, 2026, 2 days before it was made public.
ACAD has moved +0.2% since the trade date, from $26.34 to $26.39 (Sep 21, 2026 close).
- Traded
- Jul 29, 2026
- Disclosed
- Jul 31, 2026
- Filing delay
- 2 days
- Price since
- +0.2%
- Role
- EVP, Head of Research & Dev
- Source
- SEC Form 4
More ACAD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.